Reddit status: access issues and outage reports

Problems in the last 24 hours

The graph below depicts the number of Reddit reports received over the last 24 hours by time of day. When the number of reports exceeds the baseline, represented by the red line, an outage is determined.

Most Reported Problems

The following are the most recent problems reported by Reddit users through our website.

• Website Down (47%)
• Errors (28%)
• Sign in (25%)

Live Outage Map

The most recent Reddit outage reports came from the following cities:

City	Problem Type	Report Time
Patna	Errors	6 hours ago
Monclova	Sign in	1 day ago
Nice	Errors	2 days ago
Guayaquil	Errors	12 days ago
Veracruz	Website Down	18 days ago
Bhubaneshwar	Website Down	20 days ago

Full Outage Map

Community Discussion

Tips? Frustrations? Share them here. Useful comments include a description of the problem, city and postal code.

Beware of "support numbers" or "recovery" accounts that might be posted below. Make sure to report and downvote those comments. Avoid posting your personal information.

Reddit Issues Reports

Latest outage, problems and issue reports in social media:

• 
  amellis🌟🌷 (@amary_dromellis) reported 9 seconds ago

  @RubenGallar …is there perhaps a link to the discord server(the Reddit post seems to have been deleted?)… I’m interested🥹

• 
  nath (@farfalledawg) reported 57 seconds ago

  Sometimes your problem is too much and you have to make a Reddit post

• 
  Not For The Weak (@CoastTechy) reported 1 minute ago

  @emblematicmood @bigkatt1666 @GzzUp_ You're really slow...this is referring to the dame old study. Now pull up a recent study and not not damn Google search . You wont do because you cant. I did that same Google search and the only source that pops up is Wikipedia and reddit LMAO. Holding on to a lie is pathetic

• 
  Beartooth (@BeartoothBaron) reported 2 minutes ago

  @reddit_lies I disagree. We've looked to tech to solve all our problems; the outcome is too often exemplified by cesspools like Reddit taking the place of real social interaction. The knee-jerk opposition to data centers is sometimes misguided, but it stems from real and justified concerns.

• 
  Kingading11 (@progress4truth) reported 2 minutes ago

  @ElEmGeeWun @LGarner36897 @OzPardo6 And this is an issue- how? It's nowhere near as bad as what his ex made it out to be. I say, let him off the hook and consume his works. Even his own daughter revealed on Reddit that the **** claim is bogus.

• 
  Nolanelio (@Nolanelio) reported 4 minutes ago

  @d1ruo @Abyssal_Fishie @Monterrient The abuse and manipulation idk where you get that from because the accusations were exagerated. I mean, where's the problem to have a real wish to finish a good game and not being a lazy mf. And that catfish ****, dude imbeciles from reddit created that and withouth evidences.

• 
  Hal Shin (@_halshin) reported 7 minutes ago

  @robj3d3 @AnthropicAI While I agree the lack of transparency is a huge issue, the way the info was cited is concerning: Gemini summary of a reddit post Reddit post summarizing a Botfarm article Botfarm article seems credible, but it's a sample size of 1 and from 5 months ago Why not screenshot the original article this post is referring to?

• 
  Sticky (@stickytheclown1) reported 13 minutes ago

  @carsonkrow @DonLee39137188 Same retards were tearing down 5g wireless antennas because some moron on a reddit page told them some fake science articles or how its the government is spying on them. I am surprised that some of you have the brain capacity to fire enough neurons not to get eaten by predators.

• 
  Devrim V. (@DevrimVardar) reported 18 minutes ago

  I think ChatGPT has pretty solid guardrails, but I’m extremely happy with Reddit and Roblox decision. Both could completely disappear from the face of the Earth and no one would have any problems or miss anything.

• 
  Bobby (@Bobbythirdway) reported 20 minutes ago

  Marriage has become extremely Reddit. A lot of the guys who get married today are overwhelmingly Redditors, which is why so much marriage discourse happens on Reddit. Terrible for the brand.

• 
  Bryce Cox (@brycecoxdesign1) reported 21 minutes ago

  Posting to build a habit, I have an app now on Apple and I’m building engagement very slowly, never expected overnight success. Testing with a small group right now. I’m in Reddit communities to add value. Need to lock down a paid route for scale

• 
  akin.korpe (@akinkep) reported 21 minutes ago

  What is the "best time" to post on Reddit? 🕒 We analyzed 26,000+ scored posts over the last 30 days at FindEvo, and the answer is clear: There is no such time. Yes, total post volume peaks during US morning hours (09:00-10:00 EST / 16:00-17:00 TSI). However, the ratio of high-intent potential buyers remains remarkably steady at around 4-6% throughout all 24 hours of the day. Even at 02:00 EST! People don't check the clock when they have a problem or are looking for a solution. Stop scheduling your posts by the clock and focus on the right intent instead. 🎯

• 
  Youssef Wasfy (@YoussefWGerges) reported 23 minutes ago

  @chanduuu_cs talking to people to know their problems to be able to solve it! usually people post their problems on reddit first, so reddit is more relevant. However X first and then LinkedIn can be good source too but no comparison with reddit

• 
  Falmingkitter (@MaldingKitter) reported 24 minutes ago

  @ShitpostRock I don't think I've ever ran into an issue I couldn't fix without the help of reddit, there's always been other forums or youtube videos or something else, redditors are not competent enough to be relied on it's an eternally festering **********

• 
  Rashi Umapathi (@rashiumapathi) reported 25 minutes ago

  "ChatGPT can help me figure out GTM." True. ChatGPT is great for: - Writing copy - Brainstorming frameworks - Learning concepts - Getting unstuck on tactics ChatGPT is terrible for: - Knowing your specific customer - Deciding which channel actually works for you - Building a repeatable system - Teaching you what most founders are doing wrong - Accountability when you want to quit on week 3 Here's what happens with "AI GTM": - You ask ChatGPT "How do I build GTM?" - It gives you 10 generic frameworks - You build all 10 (because why not, you can't run out of ChatGPT?) - You execute none of them well - You're busier and more confused - Still zero customers Here's what happens with a specialist: - Specialist says "Your channel is Reddit. Build THIS specific system." - You build ONE system really well - You execute it - It works - You have a repeatable revenue channel The difference? Constraint. ChatGPT gives you infinite options. A specialist gives you one right option. Founders optimize for optionality (lots of paths). Winners optimize for execution (one clear path). AI is the optionality tool. Specialists are the execution tool. If you're stuck in "too many options, not enough execution," a specialist isn't a nice-to-have. It's the thing you need. What's your honest blocker right now: Too many options or lack of execution?

• 
  Shu-Stella🔞 (@Stella_Hoshii) reported 25 minutes ago

  If you think the comments on Twitter, BSky, and Reddit are terrible, it’s because you haven’t seen Bilibili yet. By comparison, Twitter is practically paradise.

• 
  paloma ⟡ (@spoilpaloma) reported 31 minutes ago

  @alll4aria “They can just put the ******* phone down” exactly omg as if they arent a fully autonomous adult! Girl they would cook u on reddit smh

• 
  Goldenlove 🐾 (@aprilkunk) reported 31 minutes ago

  @ekatrinya You can’t always accept AI, but there are multiple resources. There are physicians discussing it in the Reddit ones. I don’t usually trust them either, but it explains why everyone is arguing it. The issue is that it is hard to find anything because it is an outlier. Thousands of medical professionals are not lying. I would take that over an expert any day. I’m in lots of groups with others and not one person in any of them have seen this ever happen. Even the ones from trauma 1 hospitals that have years of experience. I have looked at studies as well but can’t find anything in them. Those are medical. If something can’t be found anywhere, it is an anomaly. I’m not going to change your mind and that is ok. I checked all of the questionable sites and they were interviews and discussions from doctors and other medical professionals. If you don’t trust what I said, then there is nothing more I can say about it. Sorry for bothering you

• 
  matthefatt2 (@ImperialsBitch) reported 34 minutes ago

  @weak4kat No communication, says you. Don’t complain about the lack of communication when you are guilty of it yourself. That’s why people disappear on you. Oh and also imagine being so butthurt over a sub not liking you because of your bad communication, that you gotta report someone on a discord server. Reddit Mod behavior LMAO.

• 
  Kyle Harrison (@kwharrison13) reported 35 minutes ago

  @Raiddell925 Maybe. Maybe you'd be fine without data centers. But let me ask you this. Do you use credit cards, debit cards, tap-to-pay, gas pumps, vending machines, parking meters, parking apps, ATMs, online banking, mobile banking, mobile check deposit, Zelle, Venmo, PayPal, Cash App, Apple Pay, Google Pay, splitting a dinner bill, autopay on your bills, payroll that isn't a paper check, direct deposit, digital 401(k), Robinhood, Coinbase, credit score checks, loan applications, mortgage applications, car loan approval at the dealership, insurance quotes, filing an insurance claim, e-filing your taxes, gift cards, store loyalty accounts, digital coupons, rebates, buy-now-pay-later, tipping on a screen, email, text messages, iMessage, WhatsApp, Signal, group chats, voicemail transcription, spam call blocking, FaceTime, Zoom, Google Meet, Discord, Slack, video calls with grandparents, phone number lookups, checking your data usage, paying your phone bill, two-factor codes, push approvals to log in, password managers that sync, "sign in with Google," resetting a forgotten password, digital IDs in your wallet app, gym check-in apps, apartment smart locks, hotel keys on your phone, office badge apps, patient portals, seeing your test results, booking a doctor's appointment, telehealth visits, prescription refill requests, the pharmacy knowing what you're on, insurance verification at the front desk, prior authorization, continuous glucose monitors, insulin pump apps, remote pacemaker checks, CPAP data reports, hearing aid apps, therapy apps, period trackers, fertility trackers, medical alert buttons for elderly parents, symptom checkers, finding an in-network doctor, the weather app, radar, hurricane warnings, tornado warnings, flood alerts, earthquake early warning on your phone, wildfire maps, smoke maps, air quality, pollen counts, Amber alerts, emergency alerts, road closure info, Google Maps, Apple Maps, Waze, live traffic, rerouting around a crash, transit apps, real-time bus and train arrivals, tapping your phone to ride the subway, Uber, Lyft, rental car reservations, Turo, bike share, scooter share, EV charging networks, paying for a charge, phone-as-car-key, remote start, finding your parked car, over-the-air car updates, in-car navigation, in-car voice assistants, stolen vehicle tracking, road trip planning, booking flights, checking in for a flight, mobile boarding passes, seat selection, flight status, rebooking after a cancellation, bag tracking, TSA PreCheck lookups, airport wifi, booking hotels, Airbnb, Vrbo, checking into a hotel, cruise bookings, theme park tickets, ride reservations, airline miles, hotel points, currency conversion, Amazon, all online shopping, order tracking, delivery notifications, returns and exchanges, price checks in-store, self-checkout, store apps, curbside pickup, Instacart, DoorDash, Uber Eats, ordering ahead at a restaurant, OpenTable, Resy, waitlist texts, QR code menus, tipping on delivery, subscription boxes, eBay, Etsy, Facebook Marketplace, Craigslist, Poshmark, StockX, Ticketmaster, StubHub, getting into a concert with a phone ticket, Alexa, Siri, Google Assistant, smart thermostats, video doorbells, security cameras, alarm monitoring, smart locks, smart lights, robot vacuums, garage door openers, baby monitors, pet cameras, automatic pet feeders, GPS pet collars, smart sprinklers, smart fridges, app-connected air fryers, cloud printing, printer ink subscriptions, routers you manage from an app, checking if you left the stove on, iCloud, Google Photos, every photo you've taken in ten years, Dropbox, Google Drive, OneDrive, shared albums, phone backups, setting up a new phone, notes apps, calendars, contact syncing, reminders, to-do apps, document scanning, e-signing a lease, Netflix, YouTube, Hulu, Disney+, Max, Prime Video, Twitch, cloud DVR, on-demand cable, Spotify, Apple Music, podcasts, audiobooks, Kindle books, library ebook borrowing, online multiplayer games, matchmaking, cloud saves, game downloads, game patches, single-player games that phone home for a license check, Steam, PlayStation Network, Xbox Live, Nintendo Online, Roblox, Minecraft servers, fantasy football, sports scores, sports betting apps, movie tickets, Google search, Wikipedia, ChatGPT, Claude, every other AI app, Instagram, TikTok, Facebook, X, Reddit, LinkedIn, Snapchat, Pinterest, dating apps, Yelp reviews, Google reviews, news sites, Substack newsletters, blogs, forums, checking if a business is open, looking up a phone number, recipes, translation apps, Duolingo, Google Docs, Sheets, Gmail, Outlook, Microsoft 365, Teams, Notion, Figma, Canva, shared calendars, scheduling links, VPNs into work, remote desktop, timeclock apps, shift scheduling apps, requesting time off, expense reports, job applications, LinkedIn recruiters, video interviews, Canvas, Blackboard, checking your kid's grades, school lunch accounts, attendance notifications, online homework, Khan Academy, Coursera, FAFSA, student loan portals, tutoring apps, Fitbit, Apple Watch health data, Strava, Peloton, sleep tracking, smart scales, calorie tracking, meditation apps, workout apps, DMV appointments, renewing your license online, paying a parking ticket, jury duty portals, checking your property tax bill, utility accounts, outage maps, paying rent through an app, HOA portals, storage unit access codes, wedding registries, baby registries, funeral arrangements, Ancestry, 23andMe results, church livestreams, volunteer signups, or GoFundMe? If you said yes to ANY of those then you do, in fact, NEED data centers.

• 
  Z | BuzzSearch (@BuzzSearchAI) reported 36 minutes ago

  ecom courses really out here charging $997 to spend 5 hours explaining what an avatar is bro just go on reddit and tiktok the customers are literally telling u their problems for free he course guys don't tell u this bc if u knew how to do the research urself they couldn't sell u the next module the biggest scams oat if u have questions u can js ask me or any goat on X

• 
  ⛧𓆩ꨄ𓆪❦丂ㄚㄥᐯ|卂❦𓆩ꨄ𓆪⛧ (@Syliva666) reported 44 minutes ago

  @FlippeRFlappeR6 @Nightmarefoxy95 @Cheese12_09 Only go to reddit if you have a problem that the same person 8 years ago was dealing with

• 
  Colts Depression Meter 45% (@Blue_Fan_65) reported 45 minutes ago

  @LucaFury @OocTobeyM you're in the wrong place, reddit is down the street neckbeard

• 
  Fechin (@FechinLi) reported 48 minutes ago

  I've been building indie products seriously for the past few years. I'm still nowhere near where I want to be, but I've had a few small wins — and, more importantly, I've changed my mind about a lot of things. Here are 6 lessons I'm becoming increasingly convinced of: 1. Crowded markets are often better than empty ones. I used to think: If 20 products already do this, why build another one? Now I almost see it as a positive signal. Competition means the problem is real. People understand it. People are already paying for solutions. You don't need to invent a new category. You need to find an angle. A specific audience. A simpler product. Better UX. Better pricing. One painful use case the incumbents don't care enough about. And as a solo builder, your economics are completely different from a company supporting a 20-person team. You don't need to win the market. You just need a small piece of it. 2. Look for proof before you write code. I trust my own product intuition much less than I used to. Before building something, I now want evidence that someone is already making money solving the same problem. I look at: competitors and pricing App Store reviews Reddit threads support complaints social media conversations what customers love what customers hate As an indie developer, your biggest constraint isn't ideas. It's time. Spending six months validating a problem you imagined is incredibly expensive. Whenever possible, build on top of demand that has already been proven. 3. Be careful with developer tools. Developers love trying new tools. That doesn't necessarily mean they love paying for them. This is especially dangerous because, as developers, we're naturally good at spotting problems we personally have and convincing ourselves they must be great businesses. Sometimes they are. But I'm much more interested now in tools tied directly to business value: Save a company time. Reduce costs. Increase revenue. Replace expensive manual work. The closer your product is to money, the easier it usually is to justify charging for it. 4. Indie hacking is mostly resource allocation. When you're building alone, everything competes for the same resource: Your attention. Code. Design. Infrastructure. Marketing. Support. SEO. Content. Analytics. Every one of those can consume unlimited time. So the real question is: What does the customer actually pay for? If the experience is the product, obsess over the experience. If one specific function delivers 90% of the value, obsess over that function. Not every screen needs to be beautiful. Not every abstraction needs to be elegant. Not every edge case needs to be solved. Your users do not care about your technical perfectionism nearly as much as you do. 5. Payment is the strongest form of validation. People will happily tell you: "This is awesome." "I'd definitely use this." "I've been looking for something exactly like this." Those are useful signals. But they're not the same signal as: Payment successful. If hundreds of people say they love your product and nobody pays, you should probably question how painful the problem really is. And once someone does pay, pay very close attention to them. Why did they buy? What were they trying to accomplish? What almost stopped them? What would make the product indispensable? One paying customer can teach you more than a hundred compliments. 6. Charge earlier than feels comfortable. I'm increasingly skeptical of the strategy: "Get lots of free users first. Monetize later." Free users can absolutely help with feedback and distribution. But free also hides the most important question: Will anyone pay for this? Let people experience the core value, then give them a reason to pay. Don't spend months building endless free features just to make the user count look better. A product that can't make money eventually loses the ability to keep improving. There's another benefit to charging early: You're setting expectations from day one. This is a product. This is a business. If it creates enough value, it costs money. The biggest shift in my thinking has been this: A small profitable product in a proven market is often far more valuable than a clever product nobody needs. Find proven demand. Pick a narrow angle. Solve the core problem really well. Test willingness to pay early. Then keep putting your limited time into the things customers actually value. Still learning, still experimenting — but these are the lessons I wish I'd internalized much earlier.

• 
  Dmitrii Volosatov (@volosatovde) reported 51 minutes ago

  Your competitors are already writing your landing page for you. You just need to read their customers. Go to: G2 Reddit Capterra X customer testimonials Look for: → what people hate → why they switched → what they expected → what surprised them → what they wish existed → the exact words they use to describe the problem Then use that language in: your headline your landing page your ads your cold outreach Don’t guess how customers describe the problem. Steal the language they already use.

• 
  Freedom (@ActionFixesFear) reported 51 minutes ago

  $IBRX On Friday, Patrick Soon-Shiong went on the Sean Spicer show and, in one quiet sentence, described the biggest opening this drug has ever had. The UAE, he said, wants to take ANKTIVA "to the next level, which is lymphopenia," for "all cancer types." Not one cancer. The failing immune system itself. If you follow this company, you felt what happened next. The boards lit up. Stocktwits, X, Reddit, everywhere we gather, one word started bouncing around: lymphopenia, this is going to be massive. They may well be right. But here is what struck us. In all that noise, we have not seen a single person actually stop and put a number on it. We seem to split into two camps. Those who are certain it is about to be enormous, and those who have never heard the word and quietly have no idea what it even means. Both are guessing, because nobody has done the arithmetic. So we did, the way we did it for Germany a few days ago, and for the Gulf before that. We took the sentence apart, counted the patients, put a price on it, and left every dial in your hands. Nothing is signed. This is not a prediction and not advice, just pure curiosity about a question the whole board is arguing over. What fell out of the math surprised us. Build it with us below. WHAT HE ACTUALLY SAID In his words, the UAE told him: "we want you to start here, because we want to then take you to the next level, which is lymphopenia." In their eyes, he said, the drug works "for all cancer types." He was careful, over and over, to say this is the UAE, not the FDA. But the direction was unmistakable. Bladder and lung were the start. Lymphopenia, treated with a simple injection under the skin in anyone whose immune cells have fallen too low, is where they want to go, and he says they already have the data. Separately, talking about the trials he is chasing, he named one more frontier: sepsis. WHY THE UAE, AND WHY IT GOES FURTHER THAN THE FDA To see why this is not idle talk, look at what the UAE has already done. Twice. For bladder cancer, the American FDA cleared ANKTIVA for one form of the disease. The UAE went a step further and added a second group the FDA still has not cleared, and will not even rule on until January. Further than the FDA. And further than Saudi Arabia, which on bladder matched the FDA exactly. For lung cancer, the FDA has cleared nothing at all. The Gulf approved it anyway, Saudi Arabia first and then the UAE, on the trial data alone. That is the pattern. The UAE does not wait for the FDA, and it does not stop where the FDA stops. Nothing here is approved yet, and it may never be. But if it does move on lymphopenia the way it moved on bladder and lung, the question becomes not just whether it approves, but how far past the FDA it would go. AMERICA ALREADY DREW THE FIRST LINE And here is what makes it concrete. There is a program in the United States right now that already lets doctors give ANKTIVA to cancer patients whose lymphocyte counts have collapsed. It is not a full approval, it does not endorse the benefit, and it earns the company almost nothing, because these programs are provided at cost. But it matters for a simpler reason. The American system has already accepted, in practice, that these are patients this drug is meant to reach. So the floor here is that group, cancer patients with wrecked immune systems, and the ceiling is the "all cancer types" the UAE described. Sepsis, the seriously ill beyond cancer, is a separate program we will size on its own. We sized both. THE SIZE OF YOUR ARMY Think of your immune system as a standing army, and your lymphocytes, chiefly the T cells and natural killer cells, as its soldiers. Lymphopenia is simply that army falling below fighting strength. And it is not only a cancer problem. The ranks fall in cancer patients on chemotherapy or radiation, and they fall just as hard in sepsis, when an infection overwhelms the body. When too many soldiers are gone, the body can no longer hold the line and infection walks straight in. Those two sick groups, cancer and sepsis, are the ones we will count, and nothing else. There is even a headcount. It is called the ALC, and it sits on almost every blood test ever run. A large study in a leading American journal found that as that headcount falls toward 1,000, all-cause risk of dying roughly doubles, and for specific causes like cancer, heart disease and infection the risk runs several times higher. It is an association, not proof that the thin ranks themselves do the damage. But the pattern is hard to miss: the smaller the army, the worse the odds. And that is the whole point of the drug. ANKTIVA's entire job is to call up reinforcements and rebuild the count. So the thesis fits in one line: the size of your immune army predicts your survival, and this drug rebuilds the army. NOW LET'S BUILD THE NUMBER So how big is the door, if it opens? Nobody can hand you one number, because it turns on the one thing nobody has defined yet: how wide the label is. So we will not hand you a number. We will build it in front of you, in four steps, and hand you every dial. Turn any one you like. STEP ONE: COUNT THE FALLEN Start with the cancer army, because that is the part we can actually count. - The Gulf sees about 42,500 new cancers a year - Of those patients, roughly 65 percent are put on chemotherapy or radiation, the treatments that thin the ranks - Of those, somewhere between half and two thirds watch their immune army fall below strength Multiply it through and you land at about 15,000 people a year, in the Gulf alone, whose defences this drug is built to rebuild. That is the grounded floor of the pool, and every number in it comes from published cancer data. STEP TWO: THE PRICE NOBODY WILL PRINT Now what a course costs, and this is the softest number in the whole post. There is no approved price for this use, because there is no approved course for it yet: PSS described an injection under the skin, and nobody has published a dose, a schedule, or a price. So we borrow one. In America, the approved bladder course runs about 322,000 dollars. Outside America, drugs like this sell for something like 40 to 70 percent of the US price, so we will use about 175,000 dollars as a stand-in. Too high, too low? Change it. The math does not care. STEP THREE: HOW MANY ACTUALLY GET IT No new drug reaches everyone at once. It reaches a sliver first, then grows as doctors and payers come on board. So turn that dial: 5 in 100, 15 in 100, 40 in 100. STEP FOUR: NOW MULTIPLY Put the three together, 15,000 people, about 175,000 dollars a course, and the share who actually get it: - 15,000 x 175,000 x 5 percent = about 130 million a year. - 15,000 x 175,000 x 15 percent = about 400 million. - 15,000 x 175,000 x 40 percent = about a billion. Now hold that against the company as it stands today: ImmunityBio sold about 113 million dollars of everything, in all of last year. So the middle of this, on cancer alone, in one region, is already several times the entire company. And cancer is only the first of the two sick groups this drug is built for. A SECOND PROGRAM, AND A BIGGER ONE Everything to here is the cancer conversation, the one the UAE described. But the same idea, rebuilding a collapsed immune army, applies to sepsis, and that is a separate program the company is already running, not part of the UAE lymphopenia talks. Its sepsis work has an early-stage protocol already submitted to the FDA and a Phase 3 planned across Saudi Arabia, the United States and the UAE. It is earlier and less certain than the cancer work: where cancer has real survival data behind it, sepsis has only an early trial and a promising idea so far. But the pool is far larger. In the Gulf, the number of sepsis patients whose immune army falls is not 15,000. It is on the order of 90,000 a year, and that count is a rough estimate. It is the same drug, at the same price per dose. The difference is that sepsis is an emergency, not a years-long course, so a patient gets a short burst rather than the full cancer regimen, call it about 60,000 dollars a head. - 90,000 x 60,000 x 5 percent = about 270 million a year. - 90,000 x 60,000 x 15 percent = about 810 million. - 90,000 x 60,000 x 40 percent = about 2.2 billion. So the second door, if it opens, is bigger than the first. Keep them apart in your head, because they are apart in reality. At a realistic uptake, cancer lymphopenia, the one the UAE is discussing now, is worth roughly 400 million to a billion a year; and sepsis, still a planned trial, roughly 800 million to over two billion. Two separate doors, the same drug, one region. Neither is signed. AND THIS IS ON TOP OF EVERYTHING ELSE Hold on to one thing: none of this replaces what the drug already has. It adds to it. What ANKTIVA is already cleared to sell, in America today, in Europe for bladder, and in the Gulf for bladder and lung, is a real, approved business worth a few hundred million dollars a year as it ramps. Everything we just built, for lymphopenia and for sepsis, sits entirely on top of that. If these doors open, they do not add another engine. They dwarf the ones already running. The full tally is at the end. WHERE THE MONEY REALLY SITS Whichever door you are looking at, the money does not arrive as one lump, and where it sits is not what you would guess. Take the cancer middle case, about 400 million dollars a year. More than half of it, call it 220 to 260 million, is the Gulf state buying this for its own citizens, the same governments already spending well over a billion a year flying their patients abroad for care they could soon give at home. Another hundred million or so runs through the private and employer insurers that cover the expatriate majority, where cancer coverage is real but uneven. The rest, a few tens of millions, is patients sponsored in from neighbouring countries and a small tail of the wealthy who travel for what they cannot get at home. The sepsis program, if it lands, flows through the very same channels. Nothing here leans on Dubai's wellness tourism, where cancer barely registers. The full split, region by region and door by door, is in the branded table attached to this post. WHY A GOVERNMENT WOULD WRITE THAT CHECK You might reasonably ask why any government would spend this kind of money. PSS never quite spells it out. But put on a detective's hat and it takes about a minute, because he left both clues lying on the same show. Clue one: asked about the economics of people living longer, he reached for a paper in Nature Aging that puts a dollar figure on healthy years of life. Add a single year to average life expectancy, it found, and in a country the size of the United States the value runs into the tens of trillions of dollars, through a healthier, more productive population. Clue two, a few minutes earlier: he was describing the Gulf, and he made a point of their population being young, average age around thirty, and of how keeping it healthy and productive for the decades ahead is exactly what they are spending their sovereign wealth on. Lay the two side by side, and the answer is obvious. To a young, rich country doing that math, a drug that rebuilds the immune system is not a line on a health budget. It is an investment in its workforce. In its future. In the long survival of a small nation betting everything on its own people. That is why the biggest cheque here is a state cheque. THE VERSION WE THREW OUT That same logic points at a much bigger version, and it is worth being honest about why we still left it out of the numbers. Imagine treating people who are not sick at all, healthy and feeling fine, just carrying a slightly low count, on the theory that rebuilding their immune system buys them healthy years. Do that across a young, wealthy population and you can conjure single-digit billions in the Gulf, tens of billions once you add America. This is the longevity frontier PSS keeps pointing at, and the economic case for it is real. But it is a thesis, not a market. No health system reimburses an expensive injection for people who feel well today, and the proof that it extends their lives does not yet exist. So we keep it out of the cash math, as the prize beyond the prize, not a number anyone collects yet. Every figure above is sick patients, real reimbursement, real data. THE WHOLE BOARD It is easy to lose the numbers along the way, so here is the whole board laid out plainly. Only one of these is actually in the bank yet: America, where ANKTIVA is running near a 200 million dollar annual pace. Two more doors are open but barely earning, Europe, which we sized at around 120 million a year, and the Gulf's bladder and lung approvals, sized between 140 and 300 million. Approved and real, but the money has only just started to flow. And the two doors we just built, both still unsigned, both in the Gulf alone: cancer lymphopenia, the one the UAE is discussing now, worth roughly 400 million to a billion dollars a year; and sepsis, a separate planned program, worth roughly 800 million to over 2 billion. Neither indication exists yet. Yet either one, at a realistic uptake, already beats everything the drug sells on the whole planet today. And even this is not the whole board. Back in February, ImmunityBio laid out a formal three-year plan: more than a dozen cancers and over twenty trials, from pancreatic and colorectal to brain, breast and lymphoma, plus a bigger bladder filing already headed to the FDA. Most are earlier and less certain than what we sized here. But we put numbers on only a corner of that plan. Every other door is upside, and not one of them is in a single figure above. And none of it counts the developing world, the millions who could never pay for this themselves but whom a global health fund could pay to reach, which is exactly why ImmunityBio just made the former head of the World Bank its vice chairman for global access. NONE OF IT IS SIGNED One line matters more than every number above it: none of this is signed. The UAE has not approved anything for lymphopenia. PSS says he is in conversations and has the data. Conversations are not a purchase order. Everything here is the size of the prize, not a promise that anyone collects it. Every figure is a dial you can turn, and we picked what we could defend and showed our work. The receipts, every number and its source, are in the reply below. So here is the whole thing in one line. There is a number on your blood test that quietly predicts how long you live. There is a drug that can move it. And there is a government that keeps approving what the FDA will not. Put those three together and the prize, across two doors in one small region, runs from a few hundred million to many times over this entire company, before America is even in the room. None of it is signed. All of it is now on the table. And you are no longer in the dark about how big the table is.

• 
  Jahid Hussain 📈 (@JahidHussain2) reported 55 minutes ago

  Founders keep asking which channel to double down on. Wrong question. Your buyer touches 15 surfaces before they pay Google, ChatGPT, Reddit, LinkedIn, a podcast, a competitor’s comparison page. GTM is deciding how many of those you show up on. Not picking one.

• 
  Leo builds (@LeoBuilds_) reported 56 minutes ago

  Engaging with people should be simple: be respectful, don't spam, add value. If talking to someone requires reading a 20 page manual first, you're not the problem. I'm on X to speak freely. If I wanted a minefield, I'd have stayed on Reddit.

• 
  joe (@a017444) reported 56 minutes ago

  I wrote a post on reddit or some **** site a few years ago "is AI the death of opensource". lots of people pushed back, i very stupidly backed down, removed the article. AI is the death of opensource.

• 
  favored, vindicated millionaire (@SosoTheWanderer) reported 57 minutes ago

  @SkylerB97 They’re cracking down on Reddit now. From emails to search engines. Anything to limit free access to information.